Pollux Biologics is part of Pollux Advisory SA and operates through its headquarters located in Baar, Switzerland, complemented by a dedicated research center in Taiwan.
Through research excellence and state-of-the-art laboratory methodologies, Pollux Biologics stands at the frontier of new edible mushroom developments. With a dedicated research team encompassing more than 10 years of experience, Pollux Biologics employs a propietary approach of genetics, molecular biology and bioinformatics to develop a sustainable and innovative mode of production for selected bioactive metabolites.
Â
Pollux Biologics is headed by Martin Mailänder and supported by Pedro Gonçalves as well as by Aditya Setiawibawa.
Martin Mailänder
Dr. des. oec. HSG
Management and Strategy Lead of Pollux Biologics
10+ years experience in the financial and strategy field
Profound knowledge in finance, M&A and private equity
Director position at one of the largest international banks
Pedro Gonçalves
PhD in Molecural Phathology and Genetics
Head of Research of Pollux Biologics
Visiting assistant professor at the College of Medicine of the National Cheng Kung University
Postdoctoral fellow at the University of Calirfornia, Berkley
Research specialized on the interface of biology, genetics and evolution of filamentous fungi
Aditya Setiawibawa
M.A. XX
Head of Development of Pollux Biologics, in the role of an independent cosultant
XXXÂ
Martin Mailänder
Dr. oec. HSG
10+ years experience in the financial and strategy field
Profound knowledge in finance, M&A and private equity
Director position at one of the largest international banks
Pedro Gonçalves
PhD in Molecular Pathology and Genetics
Visiting assistant professor at the College of Medicine of the National Cheng Kung University
Postdoctoral fellow at the University of California, Berkeley
Research specialized on the interface of biology, genetics and evolution of filamentous fungi
Aditya Setiawibawa
M. Sc. in Molecular Biology and Biotechnology
Research specialized in molecular biology and biotechnology of natural products
manufacturing process At highest levels
Our team of experts have dedicated themselves to researching and developing the most effective cordycepin formula on the market.
The R&D center of Pollux Biologics is located in Tainan, Taiwan. With its modern facilities, equipment and fruitful exchange of ideas among the various researches, the R&D center is decisive for the success of new products and discoveries.
The R&D center is supported by Pedro Gonçalves who brings in a rich experience in fungal biodiversity, primarily at the interface of biology, genetics and evolution of filamentous fungi and Aditya Setiawibawa, with a focus on fungal biotechnology.
HIGHest PURITY CORDYCEPIN
Our cordycepin is sourced from the highest quality mushrooms and is processed using state-of-the-art technology to ensure a purity level of over 98%.